Lack of Clinical Benefit of Interferon β-1a among Patients with Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?

Manu Shankar-Hari*, Carolyn S. Calfee

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)713-715
Number of pages3
JournalJAMA - Journal of the American Medical Association
Issue number8
Publication statusPublished - 25 Feb 2020

Cite this